Neogen (NEOG)
(Delayed Data from NSDQ)
$12.14 USD
+0.18 (1.51%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $12.15 +0.01 (0.08%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth B Momentum F VGM
Income Statements
Fiscal Year end for Neogen Corporation falls in the month of May .
All items in Millions except EPS data.
5/31/23 | 5/31/22 | 5/31/21 | 5/31/20 | 5/31/19 | |
---|---|---|---|---|---|
Sales | 822 | 527 | 468 | 418 | 414 |
Cost Of Goods | 416 | 284 | 253 | 222 | 222 |
Gross Profit | 406 | 243 | 215 | 196 | 192 |
Selling & Adminstrative & Depr. & Amort Expenses | 368 | 184 | 141 | 129 | 124 |
Income After Depreciation & Amortization | 38 | 59 | 74 | 68 | 68 |
Non-Operating Income | -4 | 2 | 1 | 5 | 5 |
Interest Expense | 56 | 0 | 0 | 0 | 0 |
Pretax Income | -22 | 60 | 75 | 72 | 73 |
Income Taxes | 1 | 12 | 14 | 13 | 13 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -23 | 48 | 61 | 59 | 60 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -23 | 48 | 61 | 59 | 60 |
Depreciation Footnote | 5/31/23 | 5/31/22 | 5/31/21 | 5/31/20 | 5/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 129 | 82 | 95 | 86 | 86 |
Depreciation & Amortization (Cash Flow) | 91 | 24 | 21 | 18 | 18 |
Income After Depreciation & Amortization | 38 | 59 | 74 | 68 | 68 |
Earnings Per Share Data | 5/31/23 | 5/31/22 | 5/31/21 | 5/31/20 | 5/31/19 |
---|---|---|---|---|---|
Average Shares | 188.88 | 108.02 | 107.12 | 105.72 | 104.85 |
Diluted EPS Before Non-Recurring Items | 0.56 | 0.63 | 0.57 | 0.57 | 0.58 |
Diluted Net EPS (GAAP) | -0.12 | 0.45 | 0.57 | 0.57 | 0.58 |
Fiscal Year end for Neogen Corporation falls in the month of May .
All items in Millions except EPS data.
2/29/24 | 11/30/23 | 8/31/23 | 5/31/23 | 2/28/23 | |
---|---|---|---|---|---|
Sales | 228.81 | 229.63 | 228.99 | 241.81 | 218.26 |
Cost Of Goods | 111.93 | 112.86 | 112.23 | 118.63 | 110.29 |
Gross Profit | 116.88 | 116.77 | 116.76 | 123.18 | 107.96 |
SG&A, R&D, and Dept/Amort Expenses | 104.86 | 102.31 | 97.62 | 99.75 | 92.28 |
Income After SG&A, R&D, and Dept/Amort Expenses | 12.02 | 14.46 | 19.14 | 23.43 | 15.68 |
Non-Operating Income | 0.44 | -0.18 | 0.98 | 2.18 | -0.48 |
Interest Expense | 18.29 | 18.03 | 18.46 | 17.96 | 17.46 |
Pretax Income | -5.82 | -3.75 | 1.66 | 7.65 | -2.26 |
Income Taxes | -3.80 | -0.26 | 0.16 | 2.08 | -10.45 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -2.02 | -3.49 | 1.50 | 5.57 | 8.19 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -2.02 | -3.49 | 1.50 | 5.57 | 8.19 |
Earnings Per Share Data | 2/29/24 | 11/30/23 | 8/31/23 | 5/31/23 | 2/28/23 |
---|---|---|---|---|---|
Average Shares | 216.60 | 216.41 | 216.85 | 216.44 | 216.40 |
Diluted EPS Before Non-Recurring Items | 0.12 | 0.11 | 0.11 | 0.14 | 0.12 |
Diluted Net EPS (GAAP) | -0.01 | -0.02 | 0.01 | -0.02 | 0.04 |